Data monetisation drives Sanofi investment in Owkin
Credit: Shutterstock.com/Golden Shrimp
Sanofi’s $180 million investment in AI biotech Owkin is the latest of several recent developments suggesting that barriers to the vast commercial potential of healthcare data are about to be torn down.
To read more
Subscribe to Global Data Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Data Review experts.
Subscribe now